Keyword Analysis & Research: shared investigator platform login

Keyword Analysis


Keyword CPC PCC Volume Score Length of keyword
shared investigator platform login1.260.291533034
shared1.430.57493156
investigator0.360.347947112
platform1.830.58670478
login1.9215866865

Keyword Research: People who searched shared investigator platform login also searched

Keyword CPC PCC Volume Score
shared investigator platform login0.130.3503326
shared investigator platform login page0.580.9634775
shared investigator platform login pfizer1.680.4491754
cognizant shared investigator platform login0.290.4273129
shared investigator platform exostar login1.20.123195
sip shared investigator platform login1.410.5323768
shared investigator platform site login1.270.9661668
shared investigator portal login0.091704973
shared investigator platform site study home0.120.648526
shared investigator platform site dashboard0.571940062
site investigator platform login1.820.2938514
sharedinvestigator.com login1.540.1619517
shared investigator platform sip login1.810.2485480
shared investigator platform pfizer1.261969523
https://www.sharedinvestigator.com/home1.790.9768736
sharedinvestigator.com0.970.7165244
https://www.sharedinvestigator.com10.2572382
www.sharedinvestigator.com1.60.4727317
shared investigator platform sip1.470.76320
shared investigator platform lilly1.60.4744337
private investigator website content0.460.1179370
private investigator website hosting1.170.9476435

Search Results related to shared investigator platform login on Search Engine

  • SIP | Registration - Shared Investigator

    sharedinvestigator.com

    https://sipidm.sharedinvestigator.com/iam/im/publicup/imcss/registration.jsp

    WEBPlease use your legal/full name when registering to SIP. Your name as entered here will be used on regulatory documents such as your Curriculum Vitae, FDA Form 1572 or equivalent, and Financial Disclosure Form. Title. Select Title (Optional) Dr. Miss Mr. Mrs. Ms. Prof. Sir. First Name.

    DA: 68 PA: 48 MOZ Rank: 23

  • Shared Investigator Platform for Clinical Trials | Cognizant

    cognizant.com

    https://www.cognizant.com/us/en/industries/life-sciences-technology-solutions/shared-investigator-platform

    WEBShared Investigator Platform (SIP) is a multi-sponsor collaborative solution for clinical trial site selection, start-up communications and management. The open design of Cognizant’s Shared Investigator Platform simplifies and accelerates clinical trials by eliminating redundant work for sponsors and clinical sites.

    DA: 60 PA: 21 MOZ Rank: 33

  • Clinical trials & Shared Investigation Platform | Cognizant

    cognizant.com

    https://www.cognizant.com/us/en/campaigns/shared-investigator-platform

    WEBIt does so all from one place, with one single sign-in. Many leading life sciences companies have joined SIP, committing to a shared vision of common workflows, training and documents, and providing a common platform for clinical trial site selection, start-up communications and study conduct.

    DA: 69 PA: 68 MOZ Rank: 68

  • SIP | Registration - Shared Investigator

    sharedinvestigator.com

    https://sipidm.sharedinvestigator.com/iam/im/publicup/imcss/termsandcondition.jsp

    WEBIf you are already registered please access Shared Investigator Platform (SIP) and login with your registered credentials or reset password. Please contact the SIP Helpdesk for further assistance.

    DA: 41 PA: 32 MOZ Rank: 46

  • Welcome to The Shared Investigator Platform

    sharedinvestigator.com

    https://sipidm.sharedinvestigator.com/iam/im/publicup/imcss/confirmemailrole.jsp

    WEBWelcome to The Shared Investigator Platform. YOUR E-MAIL ADDRESS. Confirm that the e-mail address below is your Primary Business e-mail address and is being used for all Clinical Trials across all Sponsors. Use of multiple e-mail addresses may result in multiple Exostar/SAM IDs and cause issues with your training records and Single Sign-on ...

    DA: 51 PA: 19 MOZ Rank: 22

  • TransCelerate - Shared Investigator Platform - Clinical Trials

    transceleratebiopharmainc.com

    https://www.transceleratebiopharmainc.com/initiatives/shared-investigator-platform/

    WEBThe Shared Investigator Platform (SIP) will facilitate interaction between investigators and multiple clinical trial sponsors, enabling study planning, study start-up and study conduct activities while reducing the administrative burden on site staff.

    DA: 18 PA: 46 MOZ Rank: 92

  • User account | Shared Investigator Platform (SIP)

    ucsf.edu

    https://investigator.ucsf.edu/user

    WEBUser account. Log in. Request new password. Username * Enter your Shared Investigator Platform (SIP) username. Password * Enter the password that accompanies your username.

    DA: 66 PA: 66 MOZ Rank: 63

  • Welcome | Shared Investigator Platform (SIP)

    ucsf.edu

    https://investigator.ucsf.edu/

    WEBShared Investigator Platform (SIP) is joint collaboration amongst pharmaceutical companies to create an online platform to facilitate clinical trials more efficiently in partnership with research sites. If you're an investigator: Register in SIP when sent an email. You can delegate your profile completion to staff. See how to delegate.

    DA: 46 PA: 67 MOZ Rank: 18

  • You’re invited to the future of clinical trials - Shared Investigator

    sharedinvestigator.com

    https://www.sharedinvestigator.com/sipwsstatic/documents/newsite/SIP_Brochure_for_Sites.pdf

    WEBSIP is designed to solve that problem by providing a single platform, log-in, and interface to work with multiple sponsors. Gain the ease of single sign-on. Access all of your clinical trials across all participating sponsors with a single sign-on.

    DA: 96 PA: 85 MOZ Rank: 15

  • Shared Investigator Platform

    sharedinvestigator.com

    https://www.sharedinvestigator.com/sipwsstatic/documents/siteuserhanbook.pdf

    WEBThe Shared Investigator Platform (SIP) offers a central point of access for Principal Investigators and Site Staff to interact with participating clinical trial Sponsors. SIP offers sites, harmonized content, and services to reduce the burden on investigative sites, and increased visibility to new study opportunities

    DA: 100 PA: 32 MOZ Rank: 4